Article info
Review article
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes
- Correspondence to Dr Camilla Nero, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168, Italy; camillanero{at}gmail.com
Citation
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes
Publication history
- Received January 11, 2019
- Revision received March 13, 2019
- Accepted March 22, 2019
- First published May 5, 2019.
Article Versions
- You are currently viewing a Previous version of this article (1 July 2019).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.